Sharing the same seed sequence and targeting the mRNA of the cell cycle regulator p27kip1, the overexpression of miR-221/222 promotes cell proliferation in thyroid papillary carcinoma, breast cancer, lung cancer, and hepatocellular carcinoma (HCC) [175]. This evidence concerns the gene CDKN1B and breast cancer.